ANTIPHOSPHOLIPID SYNDROME
Clinical trials for ANTIPHOSPHOLIPID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTIPHOSPHOLIPID SYNDROME trials appear
Sign up with your email to follow new studies for ANTIPHOSPHOLIPID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy tested on patients with untreatable autoimmune diseases
Disease control Recruiting nowThis is an early-stage safety study testing a single infusion of YTS109 cells in 18 adults with severe autoimmune diseases that have not responded to standard treatments. The main goal is to check for side effects and see how the body handles the cells. Researchers will also look…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New cell therapy tested for patients Who've tried everything else
Disease control Recruiting nowThis is an early safety study testing a single infusion of a new cell therapy called YTS109. It aims to see if the treatment is safe and shows any signs of helping adults with severe autoimmune diseases that have not responded to standard treatments. The study will enroll about 1…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Doctors seek best blood thinner combo for dangerous clotting disorder
Disease control Recruiting nowThis study is creating a registry to compare the safety and effectiveness of different blood-thinning medication combinations for people with antiphospholipid syndrome (APS) who have recently had an artery clot. It will follow 150 adult patients for two years, tracking whether th…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: McMaster University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Engineered immune cells target devastating autoimmune diseases in groundbreaking trial
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for people with severe autoimmune diseases that haven't improved with standard treatments. Doctors will give patients specially engineered immune cells (CAR-NK cells) to try to reset their overactive immune systems. The main go…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 18, 2026 14:55 UTC
-
Yale launches massive 5,000-Person study to unlock secrets of arthritis and autoimmune diseases
Knowledge-focused Recruiting nowThis study is creating a large collection of health information and biological samples from people with various rheumatic diseases, like rheumatoid arthritis and lupus. The goal is to help scientists compare different diseases to learn more about what causes them and how they pro…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Global effort launched to track rare blood disorder in kids
Knowledge-focused Recruiting nowThis study is creating an international registry to collect information about children with antiphospholipid syndrome (APS), a rare blood clotting disorder. Researchers aim to gather data on what causes APS and how it's treated in pediatric patients. The registry will follow 50 c…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists probe blood clot mystery in autoimmune disease
Knowledge-focused Recruiting nowThis study aims to better understand what causes dangerous blood clots in people with antiphospholipid syndrome (APS). Researchers will measure levels of a specific protein, called annexin A2, on the surface of immune cells (monocytes) in 60 adults with APS. The goal is to see if…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Hidden cause of senior strokes under investigation
Knowledge-focused Recruiting nowThis study aims to find out how common a blood clotting disorder called Antiphospholipid Syndrome (APS) is in people aged 65 and older who have had a stroke or mini-stroke (TIA). Researchers will test 400 patients for specific antibodies linked to APS to see if it's a missed caus…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: NA • Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:27 UTC